A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient Preference

Program Overview

This multi-activity CME curriculum is designed to be directed to your needs. The initial activity is interactive and fast-paced. It allows you to test your knowledge and practice through a series of case vignettes, to compare yourself to your peers and find out what the experts have to say about rheumatoid arthritis (RA). Once you have completed the activity, you will be directed to other activities in RA that may be of interest.

Credit Expired

CE Credit Expired

Target Audience

Physicians, nurse practitioners, and physician assistants who specialize in rheumatology and internal medicine.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Incorporate guideline-recommended disease activity measures into clinical practice
Select individualized treatments for patients with rheumatoid arthritis (RA) that maximize the opportunity to achieve remission and avoid relapse while minimizing toxicity
Employ a strong patient-provider collaborative approach to managing patients with RA that includes patient education, engagement, and shared decision making

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

William J. Koopman Endowed Professor in Rheumatology and Immunology
Director, UAB Arthritis Clinical Intervention Program
Co-Director, UAB Center for Education and Research on Therapeutics
(CERTS) of Musculoskeletal Disorders
Co-Director, UAB PharmacoEpidEmiology and phaRmcoeconomics (PEER) Unit
University of Alabama at Birmingham, Division of Clinical Immunology and Rheumatology
Birmingham, AL

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. 

Featured RMEI CE Activities

A Guideline-Driven Approach to RA: Disease Monitoring, Treatment Selection, and Patient Preference

Program Overview

Target Audience

Educational Objectives

Activity Faculty

Jeffrey R. Curtis, MD, MS, MPH

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

Collaboration Nation: Interprofessional Perspectives on Immunotherapy and Team-Based Care for Non-Melanoma Skin Cancer

Spinal Muscular Atrophy: An Interprofessional Approach

Tackling the Problem Head On: Key Considerations for CMV in the Post-Transplant Setting: A Care Team Forum®

Subscribe